Cosibelimab
Product Specifications
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation|||Apoptosis|||Cell Cycle/Checkpoint
Bioactivity
Cosibelimab (CK-301; TG-1501) is a fully human, high-affinity monoclonal antibody that inhibits PD-L1 by preventing its interaction with PD-1. Featuring a functional Fc domain, this compound effectively induces antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC), targeting and eliminating PD-L1+ cell lines, including lymphoma cells [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/64416431076278373/T77151
CAS Number
2216751-26-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
bsm-62423R-BF680-TR 20 µL
P66 alpha/GATAD2A Recombinant Antibody, AbBy Fluor™ 680 Conjugated
Ask
View Details 
MBS1375413-01 0.02 mg (E-Coli)
Recombinant Shigella dysenteriae Shiga toxin subunit B (stxB)
Ask
View Details MBS1375413-02 0.1 mg (E-Coli)
Recombinant Shigella dysenteriae Shiga toxin subunit B (stxB)
Ask
View Details MBS1375413-03 0.02 mg (Yeast)
Recombinant Shigella dysenteriae Shiga toxin subunit B (stxB)
Ask
View Details